Regulatory compliance is a top priority for pharmaceutical, biotech, medical device manufacturers, and other life science organizations. In particular, 21 CFR Part 11 compliance – the FDA’s regulation on electronic records and electronic signatures – is critical. Failing to meet these standards can lead to costly delays, fines, operational disruptions, and reputational damage. In this